HQH (abrdn Healthcare Investors) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HQH abrdn Healthcare Investors HQH
49 GF Score
Price $23.84
GF Value $50.26
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is abrdn Healthcare Investors Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

abrdn Healthcare Investors Valuation Rank Related Terms

HQH
49GF Score
abrdn Healthcare Investors HQH
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is abrdn Healthcare Investors (HQH) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued. The current stock price of $23.84 is trading 52.6% below its estimated GF Value™ of $50.26. GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.

Key valuation signals for HQH:

  • Valuation Rank:
  • GF Value™: $50.26 vs. price of $23.84 (52.6% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

abrdn Healthcare Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
49GF Score

Get the complete analysis for HQH

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.84
Price
$50.26
GF Value